Medartis Holding AG
ISIN: CH0386200239 | Ticker: MED
As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland. For optimized treatment and an improved quality of life for patients. Worldwide.
Year founded1997
Served areaWorldwide
Headcount680
HeadquartersHochbergstrasse 60E, 4057 Basel – Switzerland
11,818,500
IPOMarch 23, 2018
Stock exchange(s)SIX Swiss Exchange